Rivastigmine is a cholinesterase inhibitor used for the treatment of mild to moderate dementia of Alzheimer's type. It helps increase levels of acetylcholine in the brain and is available in oral capsule and transdermal patch forms. The oral capsule is prescribed for mild to moderate dementia while the transdermal patch is recommended for moderate to severe dementia, improving patient compliance.
​
The global Rivastigmine Market is estimated to be valued at US$ 516.3 Mn ... Read more

Rivastigmine is a cholinesterase inhibitor used for the treatment of mild to moderate dementia of Alzheimer's type. It helps increase levels of acetylcholine in the brain and is available in oral capsule and transdermal patch forms. The oral capsule is prescribed for mild to moderate dementia while the transdermal patch is recommended for moderate to severe dementia, improving patient compliance.
​
The global Rivastigmine Market is estimated to be valued at US$ 516.3 Mn ... Read more